Levofloxacin Prophylaxis in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation Recipients Does not Prevent Infective Complications and Infections-related Deaths - Poll - MDSpire

Levofloxacin Prophylaxis in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation Recipients Does not Prevent Infective Complications and Infections-related Deaths

  • By

  • Davide Leardini

  • Giacomo Gambuti

  • Edoardo Muratore

  • Francesco Baccelli

  • Francesca Gottardi

  • Francesco Venturelli

  • Tamara Belotti

  • Arcangelo Prete

  • Marco Fabbrini

  • Patrizia Brigidi

  • Silvia Turroni

  • Riccardo Masetti

  • December 3, 2024

  • 0 min

Share

Original Source(s)

Levofloxacin Prophylaxis in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation Recipients Does not Prevent Infective Complications and Infections-related Deaths

  • by Davide Leardini, Giacomo Gambuti, Edoardo Muratore, Francesco Baccelli, Francesca Gottardi, Francesco Venturelli, Tamara Belotti, Arcangelo Prete, Marco Fabbrini, Patrizia Brigidi, Silvia Turroni, Riccardo Masetti

  • December 3, 2024

Related Content

The lipid–inflammation axis in rosacea: mechanistic insights and therapeutic implications

The Oral Microbiome's Role: Linking Periodontal Dysbiosis to Systemic Health Issues

Colonizing Corneal Healing

Genetically engineered ocular bacteria accelerates corneal wound healing by colonizing the eye and secreting interleukin-10

  • April 17, 2026

  • 3 min